NEWS
News Articles
An Open Letter from CEO Maria Thacker-Goethe
Dear Members and Partners:There has been a pattern of social injustice toward the Black community and communities of color for too long. I have spent these recent trying days in dialogue with young community leaders, personal friends and business colleagues who are in pain, confused, scared and angry. In these calls, we have shared together…
Read MoreLanzaJet Takes Off: Innovative Sustainable Fuel Technology and Investment Structure to Accelerate Commercialization, Regional Job Growth, and Carbon Reduction
LanzaTech, a leading biotech company and carbon recycler, has successfully launched LanzaJet, Inc., a new company that will produce sustainable aviation fuel (SAF) for a sector requiring climate friendly fuel options as it starts to recover from the impacts of COVID-19. With its approach to commercialization of SAF, LanzaJet is creating regional jobs while enabling…
Read MoreBIO’s Dr. McMurry-Heath Says Racism a “Chronic Disease” Plaguing Society
In the wake of tragic deaths and civil unrest, BIO’s President and CEO Dr. Michelle McMurry-Heath announced she will lead a panel discussion next week at BIO Digital with industry leaders on the state of race and equity within the biotechnology industry. Following the announcement, Dr. McMurry-Heath shared her thoughts on events that have taken…
Read MoreHHS Provides an Additional $250 Million to Help U.S. Health Care Systems Respond to COVID-19
The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR) is providing an additional $250 million to aid U.S. health care systems treating patients and responding to the COVID-19 pandemic. As authorized by the Coronavirus Aid, Relief, and Economic Security (CARES) Act, HHS has now provided a total of…
Read MoreBIO and CSBA Letter to Congress to Support One Health and Advance Animal Biotech
The Biotechnology Innovation Organization (BIO), along with the 27 members of the Council of State Bioscience Associations (CSBA), urge Congress to support the Advancing Emergency Preparedness Through One Health Act and advance legislation directing the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) to develop a Memorandum of Understanding (MOU) to…
Read MoreSteven Damon Appointed Chief Executive Officer of Micron Biomedical, a Novel Vaccine and Therapeutic Technology Company
Micron Biomedical, Inc., an Atlanta based biopharmaceutical company, has appointed industry veteran, Steven Damon, as the company CEO. Mr. Damon will lead Micron on a path to rapid development and commercialization of Micron’s proprietary dissolvable, microneedle-based technology, a novel technology designed for simple, safe and effective self-dosing of vaccines and therapeutics. “The time is right…
Read More